HB 658: Price Increases Of Drugs Under The Managed Care Law

HB 658: Price Increases Of Drugs Under The Managed Care Law

This bill clarifies the content of provider contract standards under the managed care law. This bill is a result of the commission to study greater transparency in pharmaceutical costs and rebate programs established in 2018, 350.

New Futures supports HB 658. Click here to read.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote